Animal model development and efficacy testing
Active Awarded Last action
- Contract number
- 75N93022F00002
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,085,422
Award facts
- Contract value 100% obligated
- $12,085,422.00 Current and potential, with all options
- Completion date 81% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Change Order | $3,433,599 | |
| Original award | $8,651,823 |
About this award
Sri International received a $12.1 million delivery order from the National Institute of Allergy and Infectious Diseases (NIAID) for animal model development and efficacy testing, with performance concluding on September 29, 2027. The contract, awarded on September 19, 2022, employs a cost-plus-fixed-fee pricing structure and is not set aside for small businesses. Work will be performed at Sri International's Menlo Park, California facility, leveraging the organization's extensive experience delivering advanced research and development services across biomedical sciences and national security domains to federal agencies including NIH, DARPA, and the Air Force Research Laboratory.
Sri International has engaged three subcontractors to support contract execution. Lovelace Biomedical Research Institute, a not-for-profit preclinical research organization in Albuquerque, New Mexico, was awarded two task orders: one issued in June 2024 for a 180-day model establishment study following partial body irradiation with supportive care in cynomolgus monkeys, and a second issued in March 2026 to conduct a model establishment study with G-CSF and supportive care in rhesus monkeys to understand dose-response relationships in non-human primates. The Medical College of Wisconsin was awarded a task order in February 2023 for a non-GLP efficacy lung study in WAG/RijCmcr rats comparing research-grade and approved drug products for a medical countermeasure, with survival as the primary endpoint and blood chemistry and lung function parameters as secondary endpoints.
Quick answers
Who was awarded contract 75N93022F00002?
75N93022F00002 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 19, 2022.
How much is contract 75N93022F00002 worth?
The government has obligated $12,085,422 on 75N93022F00002.
Is contract 75N93022F00002 an order under another contract?
Yes. 75N93022F00002 is a delivery order under 75N93020D00011, an indefinite delivery contract.
Was contract 75N93022F00002 competed?
The extent of competition for 75N93022F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award